Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy | Journal for ImmunoTherapy of Cancer
Using radiation to modulate CAR T cell function | Carl DeSelm Lab | Washington University in St. Louis
Clinical use of dendritic cells for cancer therapy - The Lancet Oncology
IJMS | Free Full-Text | The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Systemic immunity in cancer | Nature Reviews Cancer
Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study | Request PDF
![PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ac5e5e50d735ecf3baed58f3854dd1fa050a509/4-Figure1-1.png "PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar")
PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar
Correlating total mutational burden with response to PD-1/L1 blockade... | Download Scientific Diagram
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
IJMS | Free Full-Text | The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Frontiers | The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Role of tumor microenvironment in EGFR-mutated NSCLC in influencing... | Download Scientific Diagram
Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance | npj Precision Oncology
Immunotherapy combined with radiotherapy to reverse immunosuppression in microsatellite stable colorectal cancer | SpringerLink
Frontiers | Immunotherapy for Glioblastoma: Current Progress and Challenges
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association
Frontiers | Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
